Will molnupiravir be a game changer in our efforts to safe COVID-19 outpatients?

Jacek Mrukowicz¹, Bram Rochwerg^{2

3

4}, Roman Jaeschke^{2

3}

Affiliations

¹ Polish Institute of Evidence Based Medicine, Kraków, Poland. jacekm@mp.pl
² Department of Medicine, McMaster University, Hamilton, Ontario, Canada
³ Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada
⁴ MAGIC Evidence Ecosystem Foundation [www.magicproject.org]

Free article

Comment

Jacek Mrukowicz et al. Pol Arch Intern Med. 2022.

Free article

. 2022 Jan 28;132(1):16183.

doi: 10.20452/pamw.16183. Epub 2022 Jan 3.

Jacek Mrukowicz¹, Bram Rochwerg^{2

3

4}, Roman Jaeschke^{2

3}

¹ Polish Institute of Evidence Based Medicine, Kraków, Poland. jacekm@mp.pl
² Department of Medicine, McMaster University, Hamilton, Ontario, Canada
³ Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada
⁴ MAGIC Evidence Ecosystem Foundation [www.magicproject.org]

No abstract available

Comment on

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.
Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, Martín-Quirós A, Caraco Y, Williams-Diaz A, Brown ML, Du J, Pedley A, Assaid C, Strizki J, Grobler JA, Shamsuddin HH, Tipping R, Wan H, Paschke A, Butterton JR, Johnson MG, De Anda C; MOVe-OUT Study Group. Jayk Bernal A, et al. N Engl J Med. 2022 Feb 10;386(6):509-520. doi: 10.1056/NEJMoa2116044. Epub 2021 Dec 16. N Engl J Med. 2022. PMID: 34914868 Free PMC article. Clinical Trial.